US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Becton Dickinson (NY:BDX)

176.80 -1.27 (-0.71%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Becton Dickinson (BDX) Q4 2025 Earnings Transcript ↗
Becton Dickinson (BDX) Q4 2025 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Market Crash: The Healthcare Stocks I'd Buy Without Hesitation ↗
Don't miss out on these opportunities. 
Via The Motley Fool
Topics Economy Stocks World Trade
News headline image
The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic Breakup
Disclaimer: This content is intended for informational purposes only and is not financial advice. Today’s date is April 9, 2026. Introduction In the high-stakes arena of medical technology, few stories... 
Via Finterra
Topics Economy World Trade
BECTON DICKINSON AND CO (NYSE:BDX) Beats Q1 FY2026 Estimates but Shares Fall in Pre-Market ↗
Via Chartmill
News headline image
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (NYSE: BDX). Known... 
Via Finterra
Topics Artificial Intelligence
News headline image
The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)
As of April 1, 2026, Becton, Dickinson and Company (NYSE: BDX), commonly known as BD, finds itself at a historic crossroads. For decades, BD was viewed as a diversified healthcare conglomerate—a... 
Via Finterra
Topics Economy Lawsuit Product Recall
News headline image
3 Large-Cap Stocks with Questionable Fundamentals
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit... 
Via StockStory
News headline image
3 Profitable Stocks We Steer Clear Of
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
Topics Economy
News headline image
3 Reasons BDX is Risky and 1 Stock to Buy Instead
Over the last six months, BD’s shares have sunk to $160.20, producing a disappointing 14.6% loss while the S&P 500 was flat. This was partly due to its softe... 
Via StockStory
Topics Stocks
News headline image
3 Healthcare Stocks Walking a Fine Line
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realiz... 
Via StockStory
News headline image
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $1,000 ↗
This Dividend King is out of favor, and this medical device peer has just introduced an exciting new product. 
Via The Motley Fool
News headline image
Baxter International (BAX) Deep Dive: Navigating the 16% Plunge and a New Strategic Era
On February 16, 2026, the mood surrounding Baxter International (NYSE: BAX) is one of cautious sobriety following a seismic shift in investor confidence. Long regarded as a defensive staple of the... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
5 Must-Read Analyst Questions From BD’s Q4 Earnings Call
Becton, Dickinson and Company’s fourth quarter results were shaped by ongoing portfolio transformation, targeted investments in growth platforms, and the headwind of international tariffs. Management... 
Via StockStory
Topics Earnings World Trade
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency
On February 11, 2026, the clinical laboratory landscape is recalibrating following a whirlwind 48 hours of financial and regulatory news. Quest Diagnostics (NYSE: DGX), the nation’s leading provider of... 
Via Finterra
Topics Artificial Intelligence
News headline image
Pure-Play Pivot: A Deep Dive into Becton Dickinson (BDX) Following the Waters Spin-Off and 2026 Guidance Reset
Becton, Dickinson and Company (NYSE: BDX), widely known as BD, has long been a cornerstone of the global healthcare infrastructure. However, as of February 11, 2026, the company is making headlines not... 
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
Which S&P500 stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
Top movers in Tuesday's pre-market session ↗
Via Chartmill
News headline image
BDX Q4 Deep Dive: Portfolio Reshaping and Product Investments Offset Tariff Headwinds
Medical technology company Becton, Dickinson and Company (NYSE:BDX) announced better-than-expected revenue in Q4 CY2025, with sales up 1.6% year on year to $5.25 billion. Its non-GAAP profit of $2.91... 
Via StockStory
Topics World Trade
Monday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Becton Dickinson BDX Q1 2026 Earnings Transcript ↗
Becton Dickinson BDX Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination
Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5... 
Via Finterra
Topics Artificial Intelligence Economy Product Recall
News headline image
BD (NYSE:BDX) Surprises With Q4 CY2025 Sales
Medical technology company Becton, Dickinson and Company (NYSE:BDX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 1.6% year on year to $5.25 billion. Its non-GAAP... 
Via StockStory
News headline image
BD Earnings: What To Look For From BDX
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting results this Monday before the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
1 Cash-Producing Stock to Consider Right Now and 2 We Find Risky
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
The healthcare landscape underwent a seismic shift in 2024, as the industry’s major players pivoted away from traditional hardware toward high-margin diagnostic platforms and artificial intelligence... 
Via MarketMinute
Topics Artificial Intelligence Economy
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >